Form 4: Sotera Health Co Director Chen Ruoxi Reports Acquisition and Disposal of Common Stock and Restricted Stock Units
SEC Form 4 Filing
Director Chen Ruoxi reports acquiring 20,089 Restricted Stock Units (RSUs) and disposing of 20,089 shares of Common Stock.
Summary
- On May 24, 2024, Chen Ruoxi, a director of Sotera Health Co, reported transactions involving the company's securities.
- Chen Ruoxi acquired 20,089 Restricted Stock Units (RSUs) under the Sotera Health Company 2020 Omnibus Incentive Plan.
- Each RSU represents the right to receive one share of Common Stock, contingent upon vesting conditions.
- The RSUs will vest fully on the earlier of the first anniversary of the grant date or the day before the next annual shareholders meeting, provided Chen Ruoxi remains a non-employee director.
- Chen Ruoxi also disposed of 20,089 shares of Common Stock.
- Following these transactions, Chen Ruoxi beneficially owns 61,649 securities, including 20,089 RSUs and 41,560 shares of Common Stock.
Sentiment
Score: 5
Explanation: This is a standard regulatory filing related to stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.
Future Outlook
The vesting of the RSUs is contingent upon Chen Ruoxi's continued service as a non-employee director.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their holdings in the company.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the transactions of a company director.
- The vesting of RSUs incentivizes the director to remain with the company.
Key Dates
| Date | Description |
|---|---|
| 11/20/2020 | Power of Attorney for Mr. Chen filed with the SEC. |
| 05/24/2024 | Date of transaction: Acquisition of 20,089 RSUs and disposal of 20,089 shares of Common Stock. |
| 05/24/2025 | Potential vesting date of RSUs (first anniversary of grant date). |
| 05/29/2024 | Date of signature by Matthew J. Klaben, Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.